RELATED CONTENT
NEWS
- Eisai's Halaven stumbles at NICE efficacy hurdle
- Scotland says no to Halaven for breast cancer and yes to Levitra for erectile dysfunction
- EMA's trial design hinders Eisai's Halaven reimbursement in Germany
- NICE U-turn puts Janssen's Zytiga ahead of Sanofi's Jevtana in prostate cancer
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

